Investor Relations

Print
Placeholder 11

Facts, figures
and details

Here you will find our results and other information relevant to the share price of Lundbeck

Latest releases

Jun 23, 2017 ı Corporate Releases

Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA

May 31, 2017 ı Corporate Releases

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

May 24, 2017 ı Corporate Releases

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

View all releases

Q1 2017 results

Read and download the Q1 2017 release and report here.

 

 

Investor presentation

Financials


Teleconference

Date 10 May 2017
Time: 13.00 pm (CEST) /
7:00am (EDT)

Webcast
Dial-ins:
DK: +45 35445583
US: +44 203 194 0544

UK: +1 855 269 2604

 

Download Center

Find more information about the financial results and related presentations at the
Download Center.


Upcoming events

› Go to calendar

Aug 09

Second quarter results 2017

Nov 08

Third quarter results 2017

› Sign up for email alerts

Share

› Go to Share

ADR

› For more information on share and ADR

Contacts

Palle Holm Olesen

Palle Holm Olesen

Vice President
Investor Relations

Phone +45 3083 2426

Contact me

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.